KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »SEARCH RESULT
Nasal Vaccine priced at Rs 800 before taxes -GS Mudur
-The Telegraph Centre’s Vaccine policy advisers earlier this week approved release of intranasal Vaccine into the private market New Delhi: Indian Vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 Vaccine, approved by the Centre as a booster dose, would be available at private hospitals for Rs 800 plus additional taxes and service charges per dose. People 18 years or older who have taken two doses of Covaxin, Covishield or any...
More »Virologist Gagandeep Kang does not expect another Covid surge in India -PT Jyothi Datta
-The Hindu Business Line The professor said, ‘Ground realities are very different in India and China’; she also called for ‘greater surveillance and sequencing’ It’s a tale of two different populations and their exposure to a virus scripts a country’s response, and the ground realities are very different between India and China, said eminent virologist Dr Gagandeep Kang. Comparing the Covid-19 situation in India and China, over the last three years, Kang told...
More »BF.7 and XBB: ‘India doing fine, masks hold little value if…’ says Dr Gagandeep Kang -Poulomi Ghosh
-Hindustan Times Virologist Dr Gagandeep Kang said India does not need restrictions but precautions but China will see a lot of infections like that of India's second wave. Virologist Dr Gagandeep Kang on Friday broke down the current Covid situation in India in comparison with China and said India is doing fine and won't require travel restrictions but China will see 'lots and lots of infections', similar to what India witnessed during...
More »After measles, experts worry typhoid could pose the next health challenge as India delays Vaccine -Tabassum Barnagarwala
-Scroll.in The country already has a high typhoid burden and increasing drug resistance could led to a rise in treatment cost and recovery time. The measles outbreak in Mumbai, followed by Ranchi, Ahmedabad and Malappuram over the past month has drawn attention to the large number of unvaccinated children. Over 16,000 suspected cases have been recorded in India. Of the 20 children who have died of measles since October 26 in the...
More »